• Trypanosoma cruzi Dysregulates piRNAs Computationally Predicted to Target IL-6 Signaling Molecules D...

• Cooley Ayorinde

• Rayford Kayla J., Arun Ashutosh, Villalta Fernando, Lima Maria F., Pratap Siddharth, Nde Pius N...

• Immune Network   2022  Volume.22  No.6 51 ~ 51

• Low-Level Expression of CD138 Marks Naturally Arising Anergic B Cells

• Lee Su-Jin

• Yang Jeong-In, Lee Hyun-Woo, Lee Ju-Hee, Kim Tae-Jin

• Immune Network   2022  Volume.22  No.6 50 ~ 50

• MiR-182-5p Mediated by Exosomes Derived From Bone Marrow Mesenchymal Stem Cell Attenuates Inflammato...

• Sun Chuang

• Li Wei, Li Yanhong, Chen Jian, An Huixian, Zeng Guangwei, Wang Tingting, Guo Yazhou, ...

• Immune Network   2022  Volume.22  No.6 49 ~ 49

• Cynomolgus Macaque Model for COVID-19 Delta Variant

• Baek Seung-Ho

• Oh Han-Seul, Koo Bon-Sang, Kim Green, Hwang Eun-Ha, An You-Jung, Park Jae-Hak, Hong Jung-J...

• Immune Network   2022  Volume.22  No.6 48 ~ 48

• Increased B Cell Understanding Puts Improved Vaccine Platforms Just Over the Horizon

• Notario Geneva Rose

• Kwak Ki-Hyuck

• Immune Network   2022  Volume.22  No.6 47 ~ 47

• Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier

• Akuzum Begum

• Lee June-Yong

• Immune Network   2022  Volume.22  No.6 46 ~ 46

• Immunologic Basis of Type 2 Biologics for Severe Asthma

• Sim So-Yoon

• Choi Young-Woo, Park Hae-Sim

• Immune Network   2022  Volume.22  No.6 45 ~ 45

• Microbial Modulation in Inflammatory Bowel Diseases

• Yu Jong-Wook

• Cheon Jae-Hee

• Immune Network   2022  Volume.22  No.6 44 ~ 44